NCT06032858View on ClinicalTrials.gov

Efficacy and Safety of Apremilast in Psoriasis

PHASE4CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

March 6, 2022

Primary Completion Date

July 10, 2023

Study Completion Date

August 10, 2023

Conditions

Psoriasis

Interventions

DRUG

Apremilast 30mg

Apremilast 30mg twice daily

Trial Locations (1)

54000

Ghurki Hospital, Lahore

All Listed Sponsors

lead

Ghurki Trust and Teaching Hospital

OTHER